O	0	1	A
O	2	12	randomized
O	13	18	trial
O	19	21	of
B-intervention	22	29	dietary
I-intervention	30	42	intervention
O	43	46	for
O	47	53	breast
O	54	60	cancer
O	61	71	prevention
O	71	72	.

O	73	86	Epidemiologic
O	87	91	data
O	92	95	and
O	96	102	animal
O	103	114	experiments
O	115	122	suggest
O	123	127	that
O	128	135	dietary
O	136	139	fat
O	140	143	may
O	144	153	influence
O	154	158	risk
O	159	161	of
O	162	168	breast
O	169	175	cancer
O	175	176	.

O	177	179	To
O	180	189	determine
O	190	197	whether
O	198	210	intervention
O	211	215	with
O	216	217	a
O	218	221	low
O	221	222	-
O	222	225	fat
O	225	226	,
O	227	231	high
O	231	232	-
O	232	244	carbohydrate
O	245	249	diet
O	250	255	would
O	256	262	reduce
O	263	269	breast
O	270	276	cancer
O	277	286	incidence
O	287	289	in
O	290	295	women
O	296	298	at
O	299	308	increased
O	309	313	risk
O	314	316	of
O	317	320	the
O	321	328	disease
O	328	329	,
O	330	332	we
O	333	340	carried
O	341	344	out
O	345	346	a
O	347	357	randomized
O	358	368	controlled
O	369	374	trial
O	375	377	in
B-location	378	384	Canada
O	384	385	.

O	386	388	We
O	389	398	recruited
B-total-participants	399	400	4
I-total-participants	400	401	,
I-total-participants	401	404	690
B-eligibility	405	410	women
I-eligibility	411	415	with
I-eligibility	416	425	extensive
I-eligibility	426	438	mammographic
I-eligibility	439	446	density
O	447	450	and
O	451	461	randomized
O	462	466	them
O	467	469	to
O	470	472	an
O	473	485	intervention
O	486	491	group
O	492	494	or
O	495	496	a
B-control	497	507	comparison
I-control	508	513	group
O	513	514	.

O	515	518	The
O	519	531	intervention
O	532	537	group
O	538	546	received
O	547	556	intensive
O	557	564	dietary
O	565	575	counseling
O	576	578	to
O	579	585	reduce
O	586	589	fat
O	590	596	intake
O	597	599	to
O	600	601	a
O	602	608	target
O	609	611	of
O	612	614	15
O	614	615	%
O	616	618	of
O	619	627	calories
O	628	631	and
O	632	640	increase
O	641	653	carbohydrate
O	654	656	to
O	657	659	65
O	659	660	%
O	661	663	of
O	664	672	calories
O	672	673	.

O	674	681	Dietary
O	682	689	intakes
O	690	694	were
O	695	703	assessed
O	704	714	throughout
O	715	720	using
O	721	725	food
O	726	733	records
O	733	734	.

O	735	743	Subjects
O	744	748	were
O	749	757	followed
O	758	761	for
O	762	764	at
O	765	770	least
O	771	772	7
O	773	778	years
O	779	782	and
O	783	786	for
O	787	789	an
O	790	797	average
O	798	800	of
O	801	803	10
O	804	809	years
O	809	810	.

O	811	814	The
O	815	819	main
O	820	827	outcome
O	828	831	was
B-outcome-Measure	832	840	invasive
I-outcome-Measure	841	847	breast
I-outcome-Measure	848	854	cancer
O	854	855	.

B-outcome	856	866	Percentage
I-outcome	867	869	of
I-outcome	870	878	calories
O	879	883	from
O	884	887	fat
O	888	890	in
O	891	894	the
O	895	907	intervention
O	908	913	group
O	914	923	decreased
O	924	928	from
O	929	931	30
O	931	932	%
B-outcome	933	935	at
I-outcome	936	944	baseline
O	945	947	to
O	948	950	20
O	950	951	%
B-outcome	952	957	after
I-outcome	958	971	randomization
O	972	975	and
O	976	984	remained
O	985	986	9
O	986	987	%
O	988	990	to
O	991	993	10
O	993	994	%
O	995	1000	lower
O	1001	1005	than
O	1006	1009	the
O	1010	1020	comparison
O	1021	1026	group
O	1027	1037	throughout
O	1037	1038	.

O	1039	1044	There
O	1045	1049	were
B-iv-bin-abs	1050	1053	118
B-outcome	1054	1062	invasive
I-outcome	1063	1069	breast
I-outcome	1070	1077	cancers
O	1078	1080	in
O	1081	1084	the
O	1085	1097	intervention
O	1098	1103	group
O	1104	1107	and
B-cv-bin-abs	1108	1111	102
O	1112	1114	in
O	1115	1118	the
O	1119	1129	comparison
O	1130	1135	group
O	1136	1137	[
O	1137	1145	adjusted
O	1146	1152	hazard
O	1153	1158	ratio
O	1159	1160	=
O	1161	1162	1
O	1162	1163	.
O	1163	1165	19
O	1166	1167	(
O	1167	1169	95
O	1169	1170	%
O	1171	1173	CI
O	1173	1174	:
O	1175	1176	0
O	1176	1177	.
O	1177	1179	91
O	1179	1180	-
O	1180	1181	1
O	1181	1182	.
O	1182	1184	55
O	1184	1185	)
O	1185	1186	]
O	1186	1187	.

O	1188	1196	Analysis
O	1197	1199	of
O	1200	1204	food
O	1205	1212	records
O	1213	1219	showed
O	1220	1224	that
O	1225	1228	fat
O	1229	1235	intake
O	1236	1238	at
O	1239	1247	baseline
O	1248	1251	and
O	1252	1257	after
O	1258	1271	randomization
O	1272	1275	was
O	1276	1279	not
O	1280	1290	associated
O	1291	1295	with
O	1296	1301	total
B-outcome	1302	1308	breast
I-outcome	1309	1315	cancer
I-outcome	1316	1325	incidence
O	1325	1326	.

O	1327	1334	Greater
B-outcome	1335	1341	weight
O	1342	1345	and
O	1346	1351	lower
B-outcome	1352	1364	carbohydrate
I-outcome	1365	1371	intake
O	1372	1374	at
O	1375	1383	baseline
O	1384	1387	and
O	1388	1393	after
O	1394	1407	randomization
O	1408	1412	were
O	1413	1423	associated
O	1424	1428	with
O	1429	1431	an
O	1432	1441	increased
O	1442	1446	risk
O	1447	1449	of
O	1450	1458	estrogen
O	1459	1467	receptor
O	1468	1469	(
O	1469	1471	ER
O	1471	1472	)
O	1472	1473	-
O	1473	1481	positive
O	1482	1488	breast
O	1489	1495	cancer
O	1495	1496	.

O	1497	1500	Our
O	1501	1509	findings
O	1510	1517	suggest
O	1518	1522	that
O	1523	1524	a
O	1525	1534	sustained
O	1535	1544	reduction
O	1545	1547	in
O	1548	1555	dietary
O	1556	1559	fat
O	1560	1566	intake
O	1567	1570	did
O	1571	1574	not
O	1575	1581	reduce
B-outcome	1582	1586	risk
I-outcome	1587	1589	of
I-outcome	1590	1596	breast
I-outcome	1597	1603	cancer
O	1604	1606	in
O	1607	1612	women
O	1613	1617	with
O	1618	1627	extensive
O	1628	1640	mammographic
O	1641	1648	density
O	1648	1649	.

O	1650	1656	Weight
O	1657	1660	and
O	1661	1673	carbohydrate
O	1674	1681	intakes
O	1682	1686	were
O	1687	1697	associated
O	1698	1702	with
O	1703	1707	risk
O	1708	1710	of
O	1711	1713	ER
O	1713	1714	-
O	1714	1722	positive
O	1723	1729	breast
O	1730	1736	cancer
O	1736	1737	.
